Evidence map›Paper›PMID 40018700›Full record

ArticleFrontiers in veterinary science2025

Simulation of a field condition to evaluate the risk of enrofloxacin-resistant

Elena Circella, Lorena Lucatello, Ludovica Montanucci, Chiara Belloli, Francesca Capolongo

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elena CircellaDepartment of Veterinary Medicine, University of Bari "Aldo Moro", Valenzano, Italy.
Lorena LucatelloDepartment of Comparative Biomedicine and Food Science, University of Padova, Legnaro, Italy.
Ludovica MontanucciDepartment of Neurology, McGovern Medical School, UTHealth, University of Texas Health Science Center at Houston, Houston, TX, United States.
Chiara BelloliDepartment of Veterinary Medicine, University of Bari "Aldo Moro", Valenzano, Italy.
Francesca CapolongoDepartment of Comparative Biomedicine and Food Science, University of Padova, Legnaro, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: In this study, we isolated Results: Here we showed that treatment with ENRO improved clinical signs in rabbits with pasteurellosis but failed to completely eradicate the pathogen, consistent with previous studies. MPC-based analysis showed acquired resistance and potential ENRO-induced shift to a lesser sensitivity in the Conclusion: These findings suggest that the current ENRO dosing regimen for pasteurellosis in rabbits is inadequate and may contribute to resistance development.

Indexed as

enrofloxacinfood-producing rabbitmedicated waterMSWPasteurella multocidaPK-PD indices

Identifiers

PMID40018700
PMCPMC11865925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.